1. T04.01.14 REAL-LIFE LONG-TERM EFFECTIVENESS AND TREATMENT PERSISTENCE OF VEDOLIZUMAB IN A SINGLE TERTIARY CARE COHORT OF CROHN'S DISEASE PATIENTS. (1st October 2020) Authors: Calandrini, L.; Salice, M.; Privitera Hrustemovic, H.; Peruzzi, G.; Rizzello, F.; Calabrese, C.; Scaioli, E.; Belluzzi, A.; Gionchetti, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. T04.01.23 SAFETY OF VEDOLIZUMAB IN THE TREATMENT OF IBD IN A SINGLE TERTIARY CENTER. (1st October 2020) Authors: Peruzzi, G.; Calandrini, L.; Privitera Hrustemovic, H.; Salice, M.; Decorato, A.; Carbone, A.; Rizzello, F.; Belluzzi, A.; Scaioli, E.; Calabrese, C.; Gionchetti, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials. (1st April 1989) Authors: Campieri, M.; Gionchetti, P.; Belluzzi, A.; Brignola, C.; Iannone, P.; Miglioli, M.; Barbara, L. Journal: Canadian Journal of Gastroenterology Issue: Volume 3:Number 2(1989) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗